Kepos Capital’s Williams Rowland Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 WRAC.WS Stock Holding History
Bought
Maintained
Sold
Other funds holding WRAC.WS
RCM
BFM
SCM
HCM
RA
EFI
BM
DC
PAMP
Kepos Capital's WRAC.WS Position: Q4 2022 in Review
Kepos Capital held its Williams Rowland Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 (WRAC.WS) position steady in Q4 2022 at 250,000 shares worth $11K. The position accounts for ﹤0.01% of the portfolio, ranked #361.
Kepos Capital first reported a position in WRAC.WS in Q3 2021 and has held it in 6 quarters since. The position peaked at $130K in Q4 2021. 37 funds tracked by Wall St. Rank hold WRAC.WS as of Q4 2022.
- Kepos Capital held 250,000 shares of Williams Rowland Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 worth $11K as of Q4 2022.
- Kepos Capital left its Williams Rowland Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 share count unchanged in Q4 2022.
- Williams Rowland Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 made up ﹤0.01% of Kepos Capital's portfolio in Q4 2022, its #361 holding.
- Kepos Capital first reported a position in Williams Rowland Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 in Q3 2021 and has held it in 6 quarters since.
- Kepos Capital's Williams Rowland Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 position peaked at $130K in Q4 2021.
- 37 funds tracked by Wall St. Rank held Williams Rowland Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 as of Q4 2022.
Based on Kepos Capital's 13F filing for Q4 2022, filed 13 Feb 2023.